| Name | Title | Contact Details |
|---|
Founded in 1991, AdCare Health Systems, Inc. (NYSE MKT: ADK) is a leading provider of senior living and health care facility management, dedicated to providing the highest quality of healthcare services to the elderly. AdCare operates 46 facilities in Alabama, Arkansas, Georgia, Ohio, Oklahoma, North Carolina, Missouri and South Carolina, with approximately 4,700 beds in service. The facilities comprise 43 skilled nursing centers, three assisted living residences and one senior independent living facility. AdCare owns 24 of the skilled nursing centers and two of the assisted living facilities, with the others operated under long-term lease, consolidated variable interest entity, or management contract.
For more than 40 years, HealthSmart has offered a wide array of customizable and scalable health plan solutions for self-funded employers. HealthSmart`s comprehensive service suite addresses individual health from all angles. This includes claims and benefits administration, provider networks, pharmacy benefit management services, business intelligence, onsite employer clinics, care management, a variety of health and wellness initiatives and web-based reporting. The Company`s headquarters is in Irving, Texas, with regional hubs throughout the country. HealthSmart`s mission is to improve member health and reduce healthcare costs.
Rotech Healthcare Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Rotech Healthcare Inc. is based in Orlando, FL. You can find more information on Rotech Healthcare Inc. at www.rotech.com
TemPharma is a Plainsboro, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
RaNA Therapeutics is pioneering the discovery of a new class of RNA-targeted medicines that selectively activate protein expression within the body`s own cells. By targeting specific genes, RaNA`s novel drugs work epigenetically to precisely upregulate the expression of beneficial proteins in order to treat or prevent disease. The company`s leadership leverages preeminent founders and advisors in the field, and the strength of its fundamental patents, technology, and know-how that underlie the discovery and development of therapeutics that selectively activate RNA. RaNA is applying its proprietary technology to rapidly advance a pipeline of novel drugs for diverse therapeutic areas, with an initial emphasis in the fields of rare genetic disorders, inflammation, oncology, metabolic diseases and neurodegenerative diseases.